Clinicopathological features of 70 desmoid-type fibromatoses confirmed by beta-catenin immunohistochemical staining and CTNNB1 mutation analysis

Summary

We reviewed 85 cases of desmoid-type fibromatosis (DF) and performed Sanger sequencing for detecting mutations in CTNNB1 and immunostaining for detecting beta-catenin localization. We included 70 DF samples, of which 56 cases demonstrated nuclear beta-catenin localization and 43 cases harboured CTNNB1 mutations. CTNNB1-mutant DF samples consistently displayed nuclear beta-catenin expression and were derived from larger-sized tumours compared to samples with wild-type CTNNB1. When we further classified DF cases into 2 subgroups based on the type of specimen, excised specimens with nuclear beta-catenin expression frequently displayed CTNNB1 mutation and no statistical correlation between nuclear beta-catenin expression and CTNNB1 mutation was observed in biopsies. When we classified CTNNB1 mutation cases into 2 subgroups (DF with T41A or T41I, and DF with S45F or S45P), T41A or T41I mutations were observed more frequently in males than in females. Additionally, DF tumours harbouring S45F or S45P mutations were located more frequently in the abdominal wall than tumours with T41A or T41I mutations. In conclusion, CTNNB1 mutation correlates with nuclear beta-catenin expression in larger or excised DF tumours, and DF harbouring CTNNB1 mutations manifest variable clinical presentations.